Published on Wednesday July 06, 2022
We are working on the following new projects:
- We signed two contracts for data management services for bioequivalence trials with Paroxetine and Desloratadine.
- We were awarded with two phase III trials with Nimesulide.
We are happy to reach the following milestones in our projects:
- The CTAs were received in the Dapagliflozinum, Gabapentin, Rosuvastatin, Hymecromone and Apixaban trials
- The 2.4 – 2.7 modules for 4 drugs were prepared.
- The CTA and import license were received in India. We are waiting for the IP import to start the enrollment.